Cimzia (certolizumab)reduces the effects of a substance in the body that can cause inflammation.. Cimzia is used to treat the symptoms of Crohn's disease after other treatments have failed.. Cimzia is also used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and non-radiographic axial spondyloarthritis. ...
Our Cimzia (certolizumab pegol) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication. This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA ...
Certolizumab (Cimzia) is an injectable protein antibody (man-made) that binds to the tumor necrosis factor alpha. Cimzia is prescribed for the treatment of rheumatoid arthritis and Crohn's disease. Side effects, drug interactions, patient safety and pregnancy information should be reviewed prior to taking any medication.
Cimzia is the brand name of the prescription drug certolizumab. It's used to treat certain autoimmune disorders, including: Rheumatoid arthritis (a condition in which the body attacks its own ...
in addition to pain at the injection site, the most common side effects seen with cimzia are upper respiratory infections -- such as a cold -- headache, high blood pressure, inflammation of the nose a
Cimzia is a biologic medication that is approved to treat adults with moderately to severely active RA. The medication is an engineered version of an antibody that acts against tumor necrosis factor alpha, a normal chemical in the immune system that causes swelling, pain, and redness. 1 All biologic medicines approved for use against RA improve the symptoms of arthritis, reduce joint damage ...
Rheumatoid arthritis, or RA, is a lifelong disease that causes inflammation, swelling, and pain in the joints. ... CIMZIA may cause serious side effects, including: CIMZIA is a prescription medicine called a Tumor Necrosis Factor (TNF) blocker that can lower the ability of your immune system to fight infections.
Real-life experiences with CIMZIA. ... People with inflammatory diseases, including rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis, especially those with very active disease, may be more likely to get lymphoma. ... The most common side effects of CIMZIA include upper respiratory infections (flu, cold), rash, and urinary ...
On April 22, 2008, Cimzia was FDA-approved to treat moderate to severely active Crohn's disease in adults who have not been helped by usual treatments. On May 14, 2009, Cimzia was approved by the FDA to treat adult patients who have moderately to severely active rheumatoid arthritis.
Certolizumab pegol (Cimzia) is an anti-TNF drug used for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Learn risks and side-effects.